Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
26.09-0.44 (-1.66%)
As of 09:49AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
22,845
18,437
32,166
6,829
0
Cost of revenue
0
-
-
0
6,000
Gross profit
3,500
-
-
6,829
-6,000
Operating expenses
Research development
78,515
75,463
50,523
38,845
23,634
Selling general and administrative
24,633
21,967
12,944
10,803
8,382
Total operating expenses
103,148
97,430
63,467
49,648
32,016
Operating income or loss
-80,303
-78,993
-31,301
-42,819
-38,016
Interest expense
-
0
484
1,434
1,394
Total other income/expenses net
-3,505
-361
408
282
3,697
Income before tax
-83,120
-78,888
-29,094
-41,618
-34,497
Income tax expense
-332
-6
-257
-23
-
Income from continuing operations
-82,788
-78,882
-28,837
-41,595
-34,497
Net income
-82,788
-78,882
-28,837
-41,595
-34,497
Net income available to common shareholders
-81,117
-77,087
-28,013
-40,027
-31,616
Basic EPS
-
-
-0.81
-1.54
-1.63
Diluted EPS
-
-
-0.81
-1.54
-1.63
Basic average shares
-
-
34,542
25,939
19,426
Diluted average shares
-
-
34,542
25,939
19,426
EBITDA
-
-77,982
-27,966
-39,755
-32,517